HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Tsuyoshi Takeda Selected Research

1-hydroxycholecalciferol (alfacalcidol)

1/2011Seven years' experience with etidronate in a woman with anorexia nervosa and vertebral fractures.
1/2011Three-year experience with combined treatment with alendronate and alfacalcidol in Japanese patients with severe bone loss and osteoporotic fracture.
8/2009Comparison of the effects of alendronate and alfacalcidol on hip bone mineral density and bone turnover in Japanese men having osteoporosis or osteopenia with clinical risk factors for fractures.
1/2009Five-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fractures.
6/2007Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry study.
7/2006Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
9/2003Treatment with vitamin D3 and/or vitamin K2 for postmenopausal osteoporosis.
1/2003Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis.
1/2003Effects of treatment with etidronate and alfacalcidol for osteogenesis imperfecta type I: a case report.
1/2002Effects of 5-year treatment with elcatonin and alfacalcidol on lumbar bone mineral density and the incidence of vertebral fractures in postmenopausal women with osteoporosis: a retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Tsuyoshi Takeda Research Topics

Disease

32Osteoporosis
03/2012 - 01/2002
26Bone Resorption
09/2012 - 01/2002
10Metabolic Bone Diseases (Osteopenia)
02/2011 - 02/2006
8Back Pain (Backache)
01/2011 - 01/2003
7Hip Fractures (Intertrochanteric Fractures)
09/2012 - 01/2006
6Postmenopausal Osteoporosis
03/2012 - 09/2003
6Body Weight (Weight, Body)
01/2011 - 01/2002
5Osteoporotic Fractures
01/2011 - 09/2003
5Vitamin K Deficiency
01/2011 - 10/2003
4Parkinson Disease (Parkinson's Disease)
09/2012 - 05/2008
4Stroke (Strokes)
03/2012 - 06/2005
4Alzheimer Disease (Alzheimer's Disease)
03/2012 - 05/2008
4Pain (Aches)
06/2009 - 01/2002
4Osteogenesis Imperfecta (Lobstein Disease)
06/2005 - 01/2002
2Osteoarthritis
01/2011 - 03/2010
2Hyperparathyroidism
01/2011 - 08/2009
2Magnesium Deficiency (Deficiency, Magnesium)
12/2006 - 04/2006
2Neoplasms (Cancer)
06/2005 - 01/2002
2Neoplasm Metastasis (Metastasis)
06/2005 - 01/2002
1Arthritis (Polyarthritis)
09/2013
1Rheumatoid Arthritis
09/2013
1Peptic Ulcer (Peptic Ulcers)
05/2012
1Atrial Fibrillation
08/2011
1Osteonecrosis (Kienbock's Disease)
08/2011
1Choline Deficiency
05/2011
1Weight Loss (Weight Reduction)
05/2011
1Hyperglycemia
02/2011
1Anorexia Nervosa
01/2011
1Spondylolysis
11/2010
1Shoulder Pain
09/2007
1Hypocalcemia
08/2005
1Liver Cirrhosis (Hepatic Cirrhosis)
06/2005
1Hyperostosis
01/2004
1Liver Diseases (Liver Disease)
01/2004
1Femoral Neck Fractures
10/2003
1Leukopenia
05/2003
1Anemia
05/2003
1Hypercalcemia (Milk Alkali Syndrome)
01/2002

Drug/Important Bio-Agent (IBA)

28Alendronate (Alendronate Sodium)FDA LinkGeneric
09/2012 - 01/2002
15Vitamin K 2 (Vitamin K2)IBA
09/2012 - 01/2003
15risedronic acid (risedronate)FDA LinkGeneric
09/2012 - 10/2003
14Etidronic Acid (HEDP)FDA LinkGeneric
03/2012 - 01/2002
11Collagen Type I (Type I Collagen)IBA
01/2011 - 01/2002
101-hydroxycholecalciferol (alfacalcidol)IBA
01/2011 - 01/2002
8CalciumIBA
01/2011 - 07/2004
7OsteocalcinIBA
09/2012 - 09/2003
7DiphosphonatesIBA
09/2012 - 10/2003
6menatetrenoneIBA
09/2012 - 09/2003
5Vitamin DFDA LinkGeneric
09/2012 - 06/2005
5Raloxifene (Evista)FDA Link
03/2012 - 01/2006
5Parathyroid Hormone (Parathormone)IBA
11/2007 - 01/2004
4Alkaline PhosphataseIBA
01/2011 - 01/2008
3ruberythric acid (AlP)IBA
08/2011 - 08/2004
3Calcitriol (Calcijex)FDA LinkGeneric
07/2006 - 06/2005
2VitaminsIBA
02/2011 - 01/2004
2elcatoninIBA
06/2009 - 01/2002
2StrontiumIBA
11/2007 - 05/2006
2ibandronic acid (Boniva)FDA Link
11/2007 - 05/2006
2Glutamic Acid (Glutamate)FDA Link
10/2003 - 09/2003
1Rheumatoid FactorIBA
09/2013
1Immunoglobulin M (IgM)IBA
09/2013
1AntibodiesIBA
09/2013
1cyclic citrullinated peptideIBA
09/2013
1C-Reactive ProteinIBA
09/2013
1hydroxide ionIBA
09/2012
1infliximab (Remicade)FDA Link
05/2012
1adalimumab (Humira)FDA Link
05/2012
1YM 529IBA
03/2012
1bazedoxifene acetateIBA
03/2012
1Bone Density Conservation AgentsIBA
03/2012
1LipidsIBA
05/2011
1Methionine (L-Methionine)FDA Link
05/2011
1Streptozocin (Streptozotocin)FDA Link
02/2011
1Teriparatide (Parathar)FDA Link
01/2011
1Anabolic AgentsIBA
01/2011
125-hydroxyvitamin DIBA
01/2011
1LeptinIBA
01/2011
1Vitamin K 1 (Phylloquinone)FDA LinkGeneric
04/2009
1Methylprednisolone Hemisuccinate (A-MethaPred)FDA LinkGeneric
06/2007
1strontium ranelate (protelos)IBA
05/2006
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
05/2006
1Prednisolone (Predate)FDA LinkGeneric
04/2006
1Testosterone (Sustanon)FDA Link
06/2005
1PhosphorusIBA
08/2004
11,25-dihydroxyvitamin DIBA
01/2004
1Cholecalciferol (Vitamin D3)FDA Link
09/2003
1Fluorouracil (Carac)FDA LinkGeneric
05/2003
1Morphine (MS Contin)FDA LinkGeneric
01/2002
1Tetracycline (Achromycin)FDA LinkGeneric
01/2002
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2002

Therapy/Procedure

2Aftercare (After-Treatment)
11/2010 - 06/2003
2Activities of Daily Living (ADL)
12/2003 - 01/2002
1Gastrectomy
03/2010
1Drug Therapy (Chemotherapy)
08/2009
1Orchiectomy (Orchidectomy)
02/2008
1Muscle Stretching Exercises (Stretching, Static)
09/2007
1Hypophysectomy
04/2007
1Arthroplasty
06/2005
1Ovariectomy (Oophorectomy)
01/2005
1Laminectomy
01/2002